---
title: "Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288912285.md"
description: "Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News"
datetime: "2026-06-05T15:35:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288912285.md)
  - [en](https://longbridge.com/en/news/288912285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288912285.md)
generator: "portal-rs"
---

# Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study | BMEA Stock News

### Related Stocks

- [BMEA.US](https://longbridge.com/en/quote/BMEA.US.md)

## Related News & Research

- [Biomea Fusion completes enrollment in COVALENT-211 Phase II icovamenib trial in insulin-deficient type 2 diabetes](https://longbridge.com/en/news/296776922.md)
- [Citi Predicts Up to 410% Rally for These 2 'Strong Buy' Stocks](https://longbridge.com/en/news/296679616.md)
- [Cocoa Crashed This Year. So Why Is Your Halloween Candy Still This Pricey?](https://longbridge.com/en/news/298054892.md)
- [NewAmsterdam Pharma (NAMS) Heads To ESC 2026 With Phase 3 Data, Is It Still 76% Below Fair Value?](https://longbridge.com/en/news/298060195.md)
- [05:04 ETFor Pulmonary Fibrosis Awareness Month, American Lung Association Highlights Free Program to Help People Learn to Live With PF](https://longbridge.com/en/news/297625071.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**